Redefining Remission Induction Chemotherapy Ineligibility by Early Mortality in De Novo Acute Myeloid Leukemia.

Li, You-Cheng; Shih, Yu-Hsuan; Chen, Tsung-Chih; Gau, Jyh-Pyng; Su, Yu-Chen; Chen, Mei-Hui; Hsu, Chiann-Yi; Liao, Cai-Sian; Teng, Chieh-Lin Jerry

Li, You-Cheng; Shih, Yu-Hsuan; Chen, Tsung-Chih; Gau, Jyh-Pyng; Su, Yu-Chen; Chen, Mei-Hui; Hsu, Chiann-Yi; Liao, Cai-Sian; Teng, Chieh-Lin Jerry.

Afiliação

Li YC; Division of Hematology/Medical Oncology, Department of Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Shih YH; Division of Hematology/Medical Oncology, Department of Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Chen TC; Division of Hematology/Medical Oncology, Department of Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Gau JP; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 10617, Taiwan.
Su YC; Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei 40705, Taiwan.
Chen MH; School of Medicine, National Yang Ming Chiao Tung University, Taipei 112201, Taiwan.
Hsu CY; Division of Hematology/Medical Oncology, Department of Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Liao CS; Department of Nursing, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Teng CJ; Division of Hematology/Medical Oncology, Department of Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan.

J Clin Med ; 10(24)2021 Dec 09.

Article em En | MEDLINE | ID: mdl-34945065

Palavras-chave

AML; LDH; age; early mortality; performance status

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google